Eisai to Launch Leqembi (Lecanemab) in Japan for the Treatment of Alzheimer's Disease (AD)

By PharmaShots

Shots: Eisai expect to launch Leqembi (lecanemab) in Japan on Dec 20, following its inclusion in the Japan NHI Drug Price List. The drug has received approval in Japan for both manufacturing & marketing for slowing the progression of MCI & mild dementia due to AD Th

You are viewing a robot-friendly page.Click hereto reload in standard format.